To establish whether insulin resistance and/or postprandial fatty acid metabolism might contribute to familial combined hyperlipidemia (FCH) we have examined parameters of insulin resistance and lipid metabolism in six FCH kindreds. Probands and relatives (n = 56) were divided into three tertiles on the basis of fasting plasma triglycerides (TG). Individuals in the highest tertile (TG > 2.5 mM; n = 14) were older and had increased body mass index, systolic blood pressure, and fasting plasma insulin concentrations compared with individuals in the lowest tertile (n = 24). The former also presented with decreased HDL cholesterol and increased total plasma cholesterol, HDL-TG, and apoprotein B, E, and CIII concentrations.
Introduction
The majority of hyperlipidemic survivors of premature myocardial infarction and cerebral stroke have familial combined hyperlipidemia (FCH)' ( 1, 2) . The incidence of FCH may be as high as 1% in Western societies ( 1, 3) . Multiple-type hyperlipidemia in combination with elevated concentrations of apolipoprotein (apo) B and a history of premature coronary heart disease (CHD) in first degree relatives are characteristic features of FCH (1) (2) (3) (4) (5) . Manifest hyperlipidemia in FCH usually does not occur before the age of 20 yr (3, 5) , although a recent report demonstrated the presence of the FCH phenotype in 67% ofchildren with familial hyperlipidemia (6) . At present, a clinical marker specific for FCH is not available and family studies are necessary to establish the diagnosis (3) (4) (5) . Several reports have documented hepatic overproduction of VLDLapo BI00 in FCH subjects (4, (7) (8) (9) . The spectrum ofFCH also comprises hyperapobetalipoproteinemia (hyperapoB) ( 10) and partial lipoprotein lipase (LPL) deficiency ( 1) . Associations with the X2 allele of the apo AI-CIII-AIV gene cluster have been demonstrated in half of the FCH families ( 12) . Increased concentrations of VLDL remnants (intermediate density lipoproteins) and increased synthesis of LDL, both metabolic products of hepatic VLDL, are likely to contribute to the atherosclerotic process (3, 5) . We have recently demonstrated that chylomicron remnant clearance is delayed in FCH patients ( 13) . Insulin resistance which has been associated to increased atherosclerotic risk ( 14) , has also been associated with FCH ( 15 ) . In subjects with the syndrome ofinsulin resistance, also known as "syndrome X" ( 16, 17) , "familial dyslipidemic hypertension" ( 15, 18) , or the "deadly quartet" ( 19) , clustering of risk factors may be found. This atherosclerotic state has also been called the "atherogenic lipoprotein phenotype" (20) and a candidate gene cluster comprising the insulin receptor and LDL receptor genes has been found on the short arm of chromosome 19 (21) .
The aim of the present study was to evaluate in FCH kindreds the relationship among lipids, apolipoproteins, and markers associated with the syndrome of insulin resistance.
Methods
Index FCHpatients (Table I ). The study protocol was approved by the Human Investigations Review Committee of the University Hospital Utrecht. Six unrelated male patients with FCH were recruited from the Lipid Clinic ofthe Utrecht University Hospital. These subjects met the following criteria: (a) a primary hyperlipidemia with varying phenotypic expression (fasting plasma cholesterol > 6.5 mM and/or fasting (n) (11) (13) (15) (6) Family studies. 50 direct FCH relatives from these six kindreds were studied. These relatives were parents, siblings, children, nephews, and nieces of the index patients. They attended our department for collection of fasting blood specimens and physical examination.
Familial hypertriglyceridemia controls (FHTG). Five hypertriglyceridemic male subjects (45.4±3.0 (SEM) yr) with normal apo B (0.83±0.06 g/liter) from families with primary hypertriglyceridemia were studied as a control group (4, 5) . None ofthese subjects was obese (body mass index < 30 kg/im2).
Analysis of the XJX2 apo AI-CIII-AIV polymorphism. The presence of the X2 minor allele which results from a polymorphic XmnI restriction site (Xl major allele) at the 5' end of the apo Al gene on chromosome 1, was determined in DNA isolated from EDTA blood as described ( 12) . These samples were sent by mail, at room temperature, and were always received 1 d later.
Oralfat-loading tests. In order to study the postprandial fatty acid metabolism in FCH and control subjects, nonesterified fatty acids (NEFA) were monitored after a standardized oral fat load in five unrelated hypertriglyceridemic FCH male probands (fasting TG 6.2±2.4 mM, cholesterol 8.4+2. 4 fat emulsion with a P/S ratio of0.06, which contains 0.001% (wt/vol) cholesterol and 2.8% (wt/ vol) carbohydrates. After an overnight fast of 12 h, the subjects ingested the fresh cream, to which 120,000 U aqueous retinyl palmitate (RP) had been added 18 h before the test, in a dose of 50 g/m2 body surface. After the ingestion of the fat load, subjects were only allowed to drink water during the following 24 h. Peripheral blood samples were obtained before (t = 0), at hourly intervals up to 10 h, and at 12, 14, and 24 h after the meal in sodium EDTA (2 mg/ ml). The results ofthe oral fat loading tests have been published separately in detail ( 13 Analytical methods. Venous blood after an overnight fast of 12 h was drawn for biochemical analysis. Fasting plasma insulin was assayed by use of a commercial radioimmunoassay kit (Phadaseph Insulin RIA, Pharmacia, Uppsala, Sweden) and glucose was determined by the glucose oxidase method (22) . TG and cholesterol (chol) were measured in duplicate by commercial colorimetric assay (GPO-PAP, Boehringer Mannheim no. 701912 and Monotest cholesterol kit, Boehringer Mannheim no. 237574, respectively) (22) . HDL was prepared from whole plasma by precipitation with phosphotungstate-MgCl2 as described (22) . Plasma apo B and apo Al were determined by immunoturbidimetry (22, 23) . Plasma apo E was measured by commercial immunoturbidimetric assays (Daiichi Pure Chemicals Ltd., Tokyo, Japan) according to manufacturer's instructions (24) . Plasma apo CIII was measured by radial immunodiffusion using plates and apo CIII standards, according to manufacturer's instructions (Daiichi Pure Chemicals Ltd.). The diameter of the precipitation ring was measured by an investigator unaware of the specimens' identity. Postheparin plasma LPL and hepatic lipase (HL) activities were determined by the release of free fatty acids from '4C-labeled trioleoyl emulsion, according to Huttunen et al. (25) as described (22) . Lipolytic activity is expressed as nmol free fatty acids min-' (mU) per ml plasma. Apo E phenotypes were determined by the single-dimension isoelectric focusing technique of VLDL isolated by ultracentrifugation in a model 40 Data are given as mean±SEM.
* Reference values for nine normolipidemic male controls without FCH (13) .
lated by repeated measures ANOVA and Fisher's least significant difference test. Mean differences between two groups were calculated by the unpaired t test. Statistical significance was reached when P < 0.05 (two-tailed).
Results
General characteristics, plasma lipids, and apoproteins ofFCH relatives (Table II ; Fig. 1 (Tables III-V) . Because elevated plasma TG concentrations are a common characteristic feature of FCH and insulin resistance, we have divided the relatives in the FCH kindreds into three tertiles of fasting plasma TG concentrations (Table III) . This approach resulted in clustering of FCH phenotype-positive subjects in the highest tertile. The subjects in the highest tertile had decreased concentrations of HDL cholesterol and increased concentrations of plasma cholesterol, as well as plasma apoproteins B, E, and CIII. None ofthe subjects in the lowest tertile used lipid lowering medication or had elevated plasma cholesterol concentrations. The characteristic features of the syndrome of insulin resistance in the three tertiles of plasma TG are listed in Table  IV . The subjects in the highest TG tertile were significantly older, had a higher body mass index, raised systolic blood pressure and increased fasting insulin concentrations. By ANOVA, a trend was found which suggested elevated NEFA plasma concentrations in hypertriglyceridemic FCH relatives compared to normolipidemic relatives in the lowest TG tertile (P = 0.09). No significant association was found between fasting NEFA plasma concentrations and fasting plasma triglycerides (r = 0.20; NS) in FCH relatives. When the nondiabetic FCH relatives were subdivided into lipoprotein phenotypes, e.g., normolipidemia (chol < 6.5 mM and TG < 2.5 mM; n = 26), hypercholesterolemia (chol > 6.5 mM and TG < 2.5 mM; n = 15), hypertriglyceridemia (chol < 6.5 mM and TG > 2.5 mM; n = 5), and combined hyperlipidemia (n = 9) fasting plasma NEFA were significantly increased in the subjects with combined hyperlipidemia compared to normolipidemic and hypercholesterolemic subjects (Table V) compared to controls (0.58±0.21 mM) (Fig. 2) . NEFA remained significantly elevated from t = 4 to t = 12 in FCH subjects with a peak at 6 h, and the course of the NEFA was different from controls (P = 0.02 by ANOVA), indicating an abnormal postprandial metabolism of fatty acids in hypertriglyceridemic FCH. Fasting plasma NEFA correlated positively to plasma RP area under the curve (r = 0.45; P = 0.02) and plasma TG area under the curve (r = 0.76; P = 0.007) (Fig. 3) , suggesting a relationship between postprandial clearance of TG-rich lipoproteins and fasting plasma NEFA. Associations with fasting plasma insulin concentrations in FCH (Fig. 4) . In FCH relatives, fasting plasma insulin correlated positively with body mass index (r = 0.57; P < 0.0001) and fasting plasma TG (r = 0.44, P = 0.001) as reported by others ( 15, 16, 19) . In addition, we also found significant positive correlations with fasting plasma apo B (r = 0.42; P = 0.002), apo CIII (r = 0.39; P = 0.005), and apo E (r = 0.37; P = 0.008). This finding suggested a relationship between atherogenic lipoproteins which contain apo B as structural apoprotein (and apo E and CIII as exchangeable apoproteins) and insulin concentrations in FCH. In addition, insulin concentrations were also positively correlated with fasting plasma glucose (r = 0.30; P = 0.04) and inversely with plasma HDL cholesterol concentrations (r = -0.29; P = 0.03). The wellknown relationship between fasting plasma TG and HDL-cholesterol concentrations was also demonstrated in FCH (Fig. 4) . When the subjects on hypolipidemic treatment were excluded from the analysis identical significant correlations were found, except for the correlation of insulin with HDL cholesterol (r --0.22; NS).
Associations ofparameters ofthe syndrome ofinsulin resistance and polymorphisms ofthe apo AI-CIII-AIVgene cluster (Table VI) . Three of the six FCH index patients studied had the X2 minor allele ofthe AI-CIII-AIV gene cluster ofchromosome 11. The XmnI restriction length polymorphisms were also determined in a subset of FCH relatives (n = 52). 21 nondiabetic relatives had an X2 allele (19 were X1X2 and 2 X2X2) and 30 nondiabetic relatives were homozygous for the Xl allele (X2 negative). Compared to the X2-negative subjects, FCH relatives with the X2 allele had significantly increased fasting plasma TG, plasma apo Al, apo CIII, and NEFA concentrations. No significant differences were found in fasting plasma cholesterol, HDL cholesterol, or plasma apoproteins B and E. Postheparin plasma LPL and hepatic lipase activities were significantly decreased in the X2-positive (n = 12) subjects compared to the X2-negative subjects (n = 13). Fasting plasma glucose and insulin concentrations were not different.
Discussion
Insulin resistance and FCH. In the present study we have demonstrated that clustering of risk factors is found in a subgroup of subjects with FCH who are characterized by elevated plasma TG and apo B concentrations. These risk factors are part ofthe syndrome of insulin resistance. Others have demonstrated a higher incidence of the syndrome of insulin resistance in FCH subjects but this was found to be associated with obesity ( 15, 18) . In the present study, obesity was not a feature in FCH subjects since the mean body mass index in the tertiles was lower than in the study ofHunt et al. ( 15) and Selby et al. ( 18) . Nonetheless, in the present study insulin concentrations correlated significantly with the body mass index in FCH relatives. Therefore, obesity does not appear to be an obligatory feature of the insulin resistance syndrome in FCH. Insulin resistance has also been associated with upper-body fat distribution measured by the waist-hip ratio (26) . An increased waist-hip ratio represents accumulation of intra-abdominal fat (27) , which may provide an increased flux of fatty acids to the liver as well as insulin resistance by an unknown mechanism ( 16 ) . In the present study we did not measure the waist-hip ratio ofour patients. However, recently we compared in our laboratory 27 hypertriglyceridemic FCH subjects (age (31 ) , who demonstrated impaired metabolism offatty acids in vitro by fibroblasts ofpatients with hyperapoB. Decreased binding, uptake and degradation of the acylationstimulating protein (i.e., basic protein I) by hyperapoB cells was responsible for the impaired fatty acid metabolism (32) (33) (34) . Increased delivery of fatty acids to hepatocytes in an vitro model has been shown to result in increased synthesis and secretion of VLDL (34, 35) , resembling the VLDL overproduction in FCH. Moreover, increased NEFA in plasma inhibits LPL which could result in slower clearance oftriglyceride rich particles from plasma (36, 37) . It cannot be excluded that elevated levels ofNEFA are responsible for the decreased lipolytic activities as found in FCH subjects (1 1, 13) . In addition, free fatty acids promote the release of LPL from the endothelial cells resulting in increased uptake ofLPL by the liver (38) . Our data therefore provide an alternative explanation for the frequently found decreased concentrations of LPL mass and LPL activity in FCH (1 1, 13) . The abnormal metabolism of fatty acids may be a characteristic feature of FCH and provide a pathophysiological link to the hepatic apo B overproduction and partial LPL deficiency that are characteristic in FCH (11, 39) .
XmnI polymorphisms and FCH. The X2 allele has been proposed as a possible marker for FCH. Three of the six FCH index patients studied had the X2 allele which is in agreement with a previous report (12) . Subjects with the X2 allele had increased concentrations of fasting plasma NEFA as well as decreased postheparin plasma LPL and HL activities. However, fasting plasma insulin concentrations were not significantly different in the X2 positive and negative subjects. In both groups the fasting plasma apo B, E, and CIII, characteristic features ofFCH subjects ( 13), were elevated. Therefore, the X2 allele may discriminate between two different pathogenetic mechanisms for the FCH phenotype, one of those related to high NEFA. In our laboratory studies are underway to investigate in detail the effect ofthe X2 allele on lipoprotein variables in FCH and non-FCH subjects.
In agreement with other authors ( 1, 3) , a high frequency of lipoprotein abnormalities was found in the spouses of affected FCH subjects. This suggests that lipoprotein parameters in these families might be largely influenced by nongenetic variables like age, diet, and smoking. This should be taken into consideration when studying genetic determinants in FCH. Extensive family studies including relatives ofthe spouses are underway in our department.
Hepatic apo B overproduction and hyperinsulinemia in FCH. Although apo B overproduction is a well established feature ofFCH (3, (7) (8) (9) , the underlying mechanism is not known. Apo B gene defects have been ruled out by linkage analysis in FCH kindreds (40) . Several studies have demonstrated that insulin decreases apo B secretion in vitro by enhanced intracellular degradation (41) (42) (43) (44) . However, the hyperinsulinemia in FCH may be a consequence of the insulin resistance and this may be associated to impaired metabolism of fatty acids by peripheral cells. In vivo evidence has been provided suggesting a pivotal role of increased fatty acids in insulin resistance (45) (46) (47) . Fatty acids activate gluconeogenesis by supplying acetylCoA which stimulates pyruvate carboxylase, one of the enzymes involved in hepatic gluconeogenesis (48, 49) . Increased production of glucose is a trigger to the pancreas to secrete insulin in order to maintain normoglycemia and this can result in increased fasting plasma insulin concentrations (50) . Therefore, we propose that the increased concentrations ofNEFA in FCH subjects may be the primary metabolic factor causing hepatic apo B overproduction (31, 34 
